Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections. [PDF]
DrugsCarbapenem-resistant Acinetobacter baumannii has been associated with over three hundred thousand annual deaths globally. It is resistant to most available antibiotics and associated with high morbidity and mortality. No global consensus currently exists for treatment strategies that balance safety and efficacy because of heterogeneity of treatment ...
Iovleva A, Fowler VG, Doi Y.
europepmc +3 more sources
The effect of Meropenem stewardship at Prof Ngoerah Hospital on the prevalence of carbapenem resistant Acinetobacter baumannii, Carbapenem-resistant Pseudomonas aeruginosa and the cost of purchasing meropenem [PDF]
Antimicrobial Stewardship & Healthcare EpidemiologyBackground: Irrational use of antibiotics will trigger anti-microbial resistance which is a threat to health problems now and in the future. The use of meropenem is often the last choice in using antibiotics without undergoing microbiological examination
Made Susila Utama +3 more
doaj +2 more sources
Personalized aerosolized bacteriophage treatment of a pulmonary infection due to carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an infant [PDF]
International Journal of Infectious DiseasesA 9-month-old ICU patient with persistent carbapenem-resistant Acinetobacter baumannii pneumonia developed a secondary infection of carbapenem-resistant Klebsiella pneumoniae.
Huiyuan Yan +15 more
doaj +2 more sources
Mechanisms of carbapenem resistance in Acinetobacter baumannii [PDF]
Infektološki glasnik, 2009 Pripadnici roda Acinetobacter su nefermentativni mikroorganizmi široko rasprostranjeni u vodi i na zemlji. Pojedine vrste unutar roda sastavni su dio fiziološke flore kože i sluznica te su sposobni preživjeti duži vremenski period na suhim i vlažnim ...
Ivana Goić-Barišić
core +2 more sources
The global epidemiology of carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]
JAC Antimicrob ResistAbstract Carbapenem-resistant Acinetobacter baumannii (CRAb) is a challenging, environmentally hardy organism with a propensity to spread within hospitals and a predilection to infect critically ill, vulnerable patients. With its potential for rapid transmission, limited treatment options, and substantial mortality, CRAb is recognized as
Boutzoukas A, Doi Y.
europepmc +2 more sources
Development and clinical application of a PCR-UV assay for detection of carbapenem resistant Acinetobacter baumannii in bloodstream infections. [PDF]
Microb Cell FactYu L +9 more
europepmc +3 more sources
Detection of the blaVIM-2 Gene in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Sudan [PDF]
International Journal of Biomedicine, 2022 Background: Acinetobacter baumannii is a pleomorphic aerobic Gram-negative bacillus that is notorious for having multidrug resistance traits. Carbapenem-resistant Acinetobacter baumannii (CRAB) is a global concern due to its ability to retain and ...
Salma Mohamed +5 more
doaj +1 more source
P-1065. Evaluating the Trends In Antimicrobial Prescriptions For Treatment Of Carbapenem Resistant Acinetobacter Baumannii Bacteremia And Clinical Outcome Differences In Polymyxin Based And Non Polymyxin Based Regimes [PDF]
Open Forum Infect Dischaitanya Prabaharan +6 more
europepmc +3 more sources
Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang
Jurnal Ilmu Kesehatan Indonesia, 2021 Acinetobacter baumannii is such a big challenge in this modern era because of their multi-drug resistance (MDR) through their resistance mechanism, namely the production of beta lactamase enzymes, one of them is oxacillinases.
Mhd. Alzaref +2 more
doaj +1 more source
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. [PDF]
PharmacotherapyKufel WD +8 more
europepmc +3 more sources